Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 11/14/2024 | $5.00 | Buy | Rodman & Renshaw |
| 1/18/2022 | $5.00 → $3.00 | Buy | HC Wainwright & Co. |
| 9/7/2021 | $5.50 → $5.00 | Buy | HC Wainwright & Co. |
4 - ROCKWELL MEDICAL, INC. (0001041024) (Issuer)
DEFA14A - ROCKWELL MEDICAL, INC. (0001041024) (Filer)
8-K - ROCKWELL MEDICAL, INC. (0001041024) (Filer)
8-K - ROCKWELL MEDICAL, INC. (0001041024) (Filer)
4/A - ROCKWELL MEDICAL, INC. (0001041024) (Issuer)
4/A - ROCKWELL MEDICAL, INC. (0001041024) (Issuer)
4/A - ROCKWELL MEDICAL, INC. (0001041024) (Issuer)
Rodman & Renshaw initiated coverage of Rockwell Medical with a rating of Buy and set a new price target of $5.00
HC Wainwright & Co. reiterated coverage of Rockwell Medical with a rating of Buy and set a new price target of $3.00 from $5.00 previously
HC Wainwright & Co. reiterated coverage of Rockwell Medical with a rating of Buy and set a new price target of $5.00 from $5.50 previously
Rockwell Medical, Inc. (the "Company") (NASDAQ:RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that the Company has renewed and extended its product purchase agreement (the "Agreement") with aQua Dialysis, LLP, a leading independent provider of in-center hemodialysis and home dialysis services in Texas. The Agreement, which includes supply and purchasing commitments, will be in effect for two years with options to renew for two additional one-year periods. Under the Agreement, Rockwell Medical will continue to supply aQua Dialysis with the Company's liquid and dry
Rockwell Medical, Inc. (the "Company") (NASDAQ:RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that the Company entered into a three-year product purchase agreement (the "Agreement") with Heritage Dialysis, a Michigan-based family-owned company comprised of dialysis professionals that specialize in providing home dialysis in skilled nursing facilities, assisted living and senior living communities, and patients' homes. The Agreement, which includes supply and purchasing commitments, will be in effect for an initial three-year term, with options to renew for three
Reports $17.3 million in net sales, $2.9 million in gross profit, and 17% gross margin in the first quarter 2026. Announces operational changes that are expected to generate more than $3 million in additional gross profit on an annualized basis. 2026 guidance reflects the Company's emphasis on growth, improved gross margin, and generating positive cash flow. Rockwell Medical, Inc. (the "Company") (NASDAQ:RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced financial and operational results for the three months ended March 31, 2026. This press release features
Rockwell Medical, Inc. (the "Company") (NASDAQ:RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that the Company appointed Joe Dawson to its board of directors. Additionally, Andrea Heslin Smiley has resigned from the Company's board of directors to pursue other endeavors. "We are pleased to welcome Joe to Rockwell Medical's board of directors. Joe is a seasoned executive who has extensive operational experience, a strong network in the renal care space, and deep domain expertise in building and scaling commercial organizations," said Robert S. Radie, Chairman of t
Rockwell Medical, Inc. (the "Company") (NASDAQ:RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that Rashad Brown has joined the Company as Vice President, Manufacturing and Supply Chain. Mr. Brown brings more than two decades of leadership experience in manufacturing operations, procurement, warehouse management, and supply chain optimization within regulated healthcare manufacturing environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251111461038/en/Rashad Brown - Vice President, Manufacturing
Universal Display Corporation (NASDAQ:OLED) (UDC), enabling energy-efficient displays and lighting with its UniversalPHOLED® technology and materials, today announced that Dr. Nigel Brown and Dr. Joan Lau have joined the Company's Board of Directors, effective March 4, 2024. The addition of these new directors expands UDC's Board to ten members. "I am pleased to welcome Nigel and Joan to the Board," said Steven V. Abramson, President and Chief Executive Officer of Universal Display Corporation and a member of the Board. "Nigel adds a wealth of business innovation, technical knowledge and corporate strategic planning expertise to our Board. Joan brings over two decades of extensive scienti
Rockwell Medical, Inc. (the "Company") (NASDAQ:RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that it will release its financial and operational results for the first quarter ended March 31, 2026 on Thursday, May 7, 2026. The Company will issue a press release at 6:00am ET followed by a live webcast at 8:00am ET. WEBCAST DETAILS Date: Thursday, May 7, 2026 Time: 8:00am ET Webcast and Replay: www.RockwellMed.com/Results Speakers: Mark Strobeck, Ph.D. — President and Chief Executive Officer Jesse Neri — SVP, Chief Financial Officer Format: Discussi
Net sales for the fourth quarter and full-year 2025 were $18.3 million and $69.3 million, respectively. Achieved profitability on an Adjusted EBITDA basis for the second consecutive year in 2025. Generated 21% in gross margin for the fourth quarter 2025, representing one of the strongest quarters for gross margin in the Company's history and a meaningful improvement over 15% gross margin for the same period in 2024. Reported $2.3 million in cash flow from operating activities in the fourth quarter 2025, which increased the Company's cash position at year-end 2025 to $25.0 million. Rockwell Medical, Inc. (the "Company") (NASDAQ:RMTI), a healthcare company that develops, manufact
Rockwell Medical, Inc. (the "Company") (NASDAQ:RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that it will release its financial and operational results for the fourth quarter and full-year ended December 31, 2025 on Thursday, March 26, 2026. The Company will issue a press release at 6:00am ET followed by a live webcast at 8:00am ET. WEBCAST DETAILS Date: Thursday, March 26, 2026 Time: 8:00am ET Webcast and Replay: www.RockwellMed.com/Results Speakers: Mark Strobeck, Ph.D. — President and Chief Executive Officer Jesse Neri — SVP, Chief Financial Off
SC 13G/A - ROCKWELL MEDICAL, INC. (0001041024) (Subject)
SC 13G/A - ROCKWELL MEDICAL, INC. (0001041024) (Subject)
SC 13D/A - ROCKWELL MEDICAL, INC. (0001041024) (Subject)